SeQuent Scientific Ltd
NSE:SEQUENT
SeQuent Scientific Ltd
NSE:SEQUENT
Price:
121.15 INR
-0.94%
Market Closed
Updated:
May 5, 2024
SeQuent Scientific Ltd
Cash from Investing Activities
|
SeQuent Scientific Ltd
Cash from Investing Activities Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
M
MANKIND
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
SeQuent Scientific Ltd
NSE:SEQUENT
|
Cash from Investing Activities
-₹526.7m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash from Investing Activities
-₹54.9B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Cash from Investing Activities
-₹25.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash from Investing Activities
-₹55.9B
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Cash from Investing Activities
₹10B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Cash from Investing Activities
-₹10.5B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is SeQuent Scientific Ltd's Cash from Investing Activities?
Cash from Investing Activities
-526.7m
INR
-526.7m
INR
Based on the financial report for Dec 31, 2023, SeQuent Scientific Ltd's Cash from Investing Activities amounts to -526.7m INR.
What is SeQuent Scientific Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-5%
-5%
Over the last year, the Cash from Investing Activities growth was 54%. The average annual Cash from Investing Activities growth rates for SeQuent Scientific Ltd have been -5% over the past three years .
You don't have any saved screeners yet
